Table 5.
Factors influencing mortality (of significant or trending towards significant influence)
| Alive at 90 days (n = 286) | Death within 90 days (n = 4) | OR (95% CI) | P-value | |
|---|---|---|---|---|
| Histopathology, n (%) | ||||
| Gangrenous cholecystitis | 102 (35.7%) | 4 (100%) | 2.8 (2.4–3.3) | 0.017 |
| Demographic, n (%) | ||||
| Age > 70 years | 107 (37.4%) | 4 (100%) | 2.7 (2.3–3.1) | 0.021 |
| Comorbidity, n (%) | ||||
| Ischaemic heart disease | 37 (12.9%) | 3 (75%) | 20.2 (2.1–199.0) | 0.009 |
| Diabetes | 36 (12.6%) | 3 (75.0%) | 20.8 (2.1–205.7) | 0.008 |
| Examination findings, n (%) | ||||
| Muscle rigidity | 48 (16.8%) | 3 (75%) | 14.8 (1.5–145.5) | 0.018 |
| Investigations, n (%) | ||||
| Pericholecystic fluid | 78 (28.1%) | 3 (75%) | 7.7 (0.8–75.1) | 0.039 |
| White cell count > 13.5 × 109/l | 91 (31.9%) | 3 (75%) | 6.4 (0.7–62.3) | 0.103 |
| Creatinine > 90 µmol/l | 84 (29.4%) | 4 (100%) | 3.4 (2.8–4.1) | 0.008 |
| Urea > 6 mmol/l | 81 (28.4%) | 4 (100%) | 3.5 (2.9–4.2) | 0.007 |
OR, odds ratio; 95% CI, 95% confidence interval.
Missing values: muscle rigidity, n = 1; urea, n = 1; creatinine, n = 1.